Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?. (May 2017)

Record Type:: Journal Article
Title:: Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?. (May 2017)
Main Title:: Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?
Authors:: Antonios, Amine
Gharios, Joseph
Tohme, Cyril
Abstract:
Is Part Of:: Future oncology. Volume 13:Number 11(2017)
Journal:: Future oncology
Issue:: Volume 13:Number 11(2017)
Issue Display:: Volume 13, Issue 11 (2017)
Year:: 2017
Volume:: 13
Issue:: 11
Issue Sort Value:: 2017-0013-0011-0000
Page Start:: 951
Page End:: 953
Publication Date:: 2017-05
Subjects:: FOLFIRINOX -- pancreatic adenocarcinoma -- resectable
Oncology -- Periodicals
616.99405
Journal URLs:: http://www.futuremedicine.com/loi/fon ↗
http://www.futuremedicine.com/ ↗
DOI:: 10.2217/fon-2017-0050 ↗
Languages:: English
ISSNs:: 1479-6694
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4060.610420
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:: 21409.xml